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Background
Substantial epidemiological evidence showed that an
adverse intrauterine environment leads to permanent
changes in physiology subsequently influencing the risk
for adult diseases.
Results
In human fetuses NOS3 expression directly correlated
with 5-hydroxymethylcytosine levels as well as H3K9ac
and H2A.Zac at the transcription start site. Using an in
vitro model for placental dysfunction we confirmed the
dynamic NOS3 response and histone acetylation pat-
terns. Concomitantly we recognized massive turnover of
Stat3 at a discrete binding site in the NOS3 promoter
upon hypoxic conditions. Moreover, knock-down
experiments targeting either STAT3 or NOS3 provided
strong evidence for a functional NOS3 and STAT3 rela-
tionship. Interestingly, induced hyperacetylation and in
vitro reporter assays showed that NOS3 expression
becomes self-attenuated by co-expression of intronic 27-
nt-ncRNA modulating STAT3 signaling.
Conclusion
We demonstrate that adaptive NOS3 regulation in
response to placental dysfunction involves differential
epigenomic signatures and that a rapid NOS3 self-limit-
ing response to an ectopic trigger co-exists with longer-
termed epigenetic changes. Persistence of such marks
might contribute to impaired vascular endothelial
response and increased risk for diseases later in life of
children who suffered from placental insufficiency.
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